The results show that low-risk BC patients have higher expression of aDCs, B cells, CD8+ T cells, NK cells, and immune function scores of APC co inhibition, Checkpoint, Inflammationpromoting, T cell coinhibition, Type I IFN Response were higher in the low-risk groups than in the high-risk groups. This evidence concerns the gene CD8A and breast cancer.